Outpatiented · Case Knowledge
Nothing dramatic happened. No loss, no major stressor, no obvious reason. The low mood arrived on its own. The heaviness, the loss of motivation, the flat emotional tone. Your doctor diagnosed depression and offered medication. Or you have been on medication and it is working somewhat but the underlying heaviness persists. In both cases, the question nobody asked is: what is producing this in the physiology? Because if there is a physiological cause and it is not addressed, the medication is covering a symptom while the source continues.
Depression Is a Brain State With a Cause
Depression is real. The suffering it produces is real. The neurotransmitter and neuroinflammatory changes that occur in depression are real and measurable. None of this is in dispute.
What is in dispute, or at least underemphasized, is that a brain producing a depressive state is responding to inputs. Those inputs can be psychological (unprocessed trauma, persistent loss, meaninglessness) or physiological (inflammatory signaling, nutrient insufficiency, hormone deficiency, sleep deprivation, gut-derived neurotransmitter disruption). They are frequently both.
The standard clinical response to depression is to assess severity, rule out suicidality, and prescribe an antidepressant. The physiological inputs are rarely assessed. A person with vitamin D of 14 ng/mL, ferritin of 20, omega-3 index below 4 percent, subclinical hypothyroidism, non-restorative sleep, and gut dysbiosis has measurable physiological causes of depression. An SSRI does not address any of them. The depression may partially improve on medication while the underlying inputs continue.
What is the brain responding to?
That is the question that almost never gets asked.
The Physiological Causes
Each of the following produces measurable changes in mood, motivation, and emotional tone through documented physiological mechanisms. Each is identifiable. Most are not investigated before medication is prescribed.
Vitamin D receptors are present throughout the brain, including the hippocampus (involved in mood regulation and memory), the prefrontal cortex (involved in motivation and emotional regulation), and the areas involved in dopamine and serotonin synthesis. Vitamin D is not a vitamin in the conventional sense. It is a steroid hormone that is synthesized in the skin and acts on receptors throughout the body and brain. Vitamin D deficiency is one of the most consistent associations with depression in the epidemiological literature. Meta-analyses of supplementation trials show meaningful mood improvement in deficient individuals. The standard lab threshold of 20 ng/mL is based on bone health. Brain function research supports optimal levels of 40 to 60 ng/mL. Seasonal affective disorder (SAD), the winter depression pattern in northern climates, is a well-documented manifestation of declining vitamin D as sun exposure decreases.
The brain is approximately 60 percent fat by dry weight. The most structurally and functionally important fats in the brain are the long-chain omega-3 fatty acids EPA and DHA. EPA has the most consistent antidepressant evidence, particularly at doses of 1 to 2 grams per day. DHA is critical for membrane fluidity in neurons, affecting how neurotransmitter receptors are positioned and function. Low omega-3 index (the proportion of EPA and DHA in red blood cell membranes, measurable by blood test) is consistently associated with depression in population studies. Many adults in Western dietary patterns have an omega-3 index below 4 percent, well below the 8 to 12 percent range associated with optimal brain and cardiovascular health. High-quality fish oil supplementation at EPA-dominant doses has effect sizes comparable to antidepressants in multiple randomized controlled trials.
The gut produces approximately 95 percent of the body's serotonin. This serotonin is produced by enterochromaffin cells in the gut lining and is regulated by the gut microbiome. Gut dysbiosis disrupts serotonin production, alters GABA signaling, changes bile acid metabolism (which affects mood), and produces inflammatory metabolites that cross into systemic circulation and reach the brain. The brain-gut axis is bidirectional: depression changes gut motility and microbiome composition, and gut dysbiosis produces depression and anxiety symptoms. Post-antibiotic depression and mood changes, mood that worsens with gut symptoms, and depression that improves with dietary intervention all reflect this axis. The gut-brain connection is one of the most active areas of depression research and is almost never considered in a standard clinical depression evaluation.
Hypothyroidism is a documented cause of depression. Thyroid hormone regulates neurotransmitter synthesis and degradation, brain energy metabolism, and neuroplasticity. Even subclinical hypothyroidism (TSH in the upper normal range, or Hashimoto's with normal TSH) is associated with depression symptoms in the research literature. A person with TSH of 3.8 and Hashimoto's TPO antibodies has thyroid-related physiological depression that will not respond optimally to antidepressants because the thyroid driver is not addressed. Depression that comes with fatigue, cold intolerance, cognitive slowing, and weight resistance is more consistent with hypothyroid-driven depression than with primary psychiatric depression. A full thyroid panel including Free T3 and TPO antibodies is warranted in anyone presenting with depression, particularly when other hypothyroid features are present.
Sex hormones have direct effects on mood, motivation, and neuroplasticity. Testosterone deficiency (hypogonadism) in men produces depression, low motivation, anhedonia (inability to experience pleasure), irritability, and cognitive slowing that is frequently misattributed to primary depression. Testosterone is not routinely checked in men presenting with depression. Estrogen and progesterone fluctuation in women produce mood symptoms at predictable phases: premenstrual dysphoric disorder, perimenopausal depression, and postpartum depression are all hormonally driven. Low estrogen reduces serotonin receptor sensitivity and dopamine tone. Low progesterone reduces GABA activity and allopregnananolone (a neurosteroid with direct antidepressant and anxiolytic effects). Sex hormones are not routinely included in a depression workup for either sex.
The inflammatory cytokines produced during chronic systemic inflammation (IL-1, IL-6, TNF-alpha) cross the blood-brain barrier and directly suppress dopamine and serotonin synthesis, activate the kynurenine pathway (which depletes tryptophan, the serotonin precursor), and drive microglial activation in the brain. This is the mechanism behind sickness behavior, the depression-like state produced by acute infection or inflammation. In chronic low-grade inflammation from gut dysbiosis, autoimmune activity, obesity, or metabolic dysfunction, this inflammatory suppression of mood pathways becomes persistent. The inflammatory theory of depression is one of the most supported and least clinically applied frameworks in current psychiatry. High-sensitivity CRP and inflammatory markers are almost never checked in a standard depression evaluation.
Sleep deprivation and depression form one of the most established bidirectional relationships in psychiatry. Poor sleep produces depression. Depression disrupts sleep. The specific sleep disruption most closely linked to depression is reduced slow-wave sleep (the deep restorative stages) and altered REM sleep timing. During non-restorative sleep, growth hormone secretion is impaired, inflammatory cytokine clearance is reduced, and emotional memory processing is disrupted. Sleep deprivation also directly reduces serotonin receptor density and dopamine signaling. Sleep improvement is one of the most effective depression interventions when addressed directly, and it is almost never treated as a primary target. Antidepressants are frequently prescribed for people with depression and sleep disturbance without addressing the sleep architecture problem that may be driving both.
Nowhere in the standard depression workup are the following routinely checked: vitamin D level, omega-3 index, full thyroid panel including Free T3 and TPO antibodies, sex hormones (testosterone in men, estrogen and progesterone in women at appropriate cycle timing), high-sensitivity CRP for inflammatory burden, ferritin, or B12 with functional markers.
Each of these can produce a clinical picture identical to major depression. Each responds to interventions that are not antidepressants. Most are inexpensive to test. The cost of checking them is a fraction of the cost of a year of antidepressant use. None are routinely ordered.
This is not an argument against antidepressants. It is an argument that prescribing a medication for a symptom without asking what is producing the symptom in the physiology is incomplete medicine. The physiological inputs should be assessed alongside the prescription, not instead of it.
Questions People Actually Ask
Can depression have a physical cause?
Yes, frequently. The brain produces a depressive state in response to physiological inputs as readily as it does to psychological ones. The most common physiological causes of depression are vitamin D deficiency (a direct brain hormone), omega-3 fatty acid deficiency (the brain requires EPA and DHA for neurotransmitter function), gut-brain axis disruption (the gut produces 95 percent of the body's serotonin), thyroid underfunction, sex hormone deficiency, chronic systemic inflammation (inflammatory cytokines directly suppress serotonin and dopamine synthesis), and sleep deprivation.
Depression that arrives without a clear psychological trigger, that comes with physical symptoms like fatigue and cold intolerance, or that began after a physiological event like childbirth, illness, or hormonal change deserves physiological investigation before the conclusion is that the cause is entirely psychological.
Can vitamin D deficiency cause depression?
Yes. Vitamin D receptors are present throughout the brain in areas involved in mood regulation, motivation, and dopamine and serotonin synthesis. Vitamin D deficiency is one of the most consistent associations with depression in epidemiological research. Meta-analyses of supplementation trials show meaningful mood improvement in deficient individuals.
Seasonal affective disorder is the most visible example: depression that follows the pattern of declining sun exposure (and therefore declining vitamin D synthesis) in winter months. But non-seasonal depression in vitamin D-deficient individuals also responds to supplementation in clinical trials.
The standard lab cutoff of 20 ng/mL is based on bone health. Brain function research supports 40 to 60 ng/mL as optimal. A vitamin D of 22 ng/mL will be reported as normal and may be contributing to depression.
Can low testosterone cause depression in men?
Yes. Testosterone has direct effects on mood, motivation, and neuroplasticity. Low testosterone (hypogonadism) in men produces depression, low motivation, anhedonia, irritability, and cognitive slowing that is clinically indistinguishable from primary depression.
Testosterone is not routinely checked in men presenting with depression. A man who is diagnosed with depression and given an antidepressant without testosterone measurement may have treatable hypogonadism that is the primary driver. The antidepressant partially compensates while the underlying cause continues.
Symptoms that make testosterone worth checking alongside a depression evaluation: reduced libido, reduced morning erections, reduced motivation and competitive drive, reduced muscle mass, and fatigue alongside depressed mood.
Does inflammation cause depression?
Yes, through a specific and well-documented mechanism. Inflammatory cytokines (IL-1, IL-6, TNF-alpha) produced during chronic systemic inflammation cross the blood-brain barrier and directly suppress serotonin and dopamine synthesis, activate the kynurenine pathway (which depletes tryptophan, the serotonin precursor), and drive microglial activation that further disrupts neurotransmitter balance.
This is why people feel depressed and unmotivated when sick: the inflammatory response to infection produces exactly the same brain state as depression, through the same pathways. In chronic low-grade inflammation from gut dysbiosis, metabolic dysfunction, or autoimmune activity, this inflammatory suppression of mood pathways becomes persistent.
High-sensitivity CRP and other inflammatory markers are almost never checked in a standard depression evaluation, despite the strength of the inflammatory theory of depression in current research.
Can gut problems cause depression?
Yes, through the gut-brain axis. The gut produces approximately 95 percent of the body's serotonin and communicates with the brain continuously through the vagus nerve, the enteric nervous system, and the systemic circulation. Gut dysbiosis disrupts serotonin production, alters GABA signaling, and produces inflammatory metabolites that reach the brain and directly affect mood pathways.
The gut-brain connection is one of the most active areas of depression research. Specific microbiome species are associated with mood regulation. Fecal microbiota transplant studies in animal models have transferred depression-like behaviors between animals. Human studies consistently show microbiome differences between depressed and non-depressed populations.
Depression that follows antibiotic use, that tracks with gut symptoms, or that improves during periods of healthier eating is consistent with gut-brain axis involvement.
The MAP Tool maps your mood pattern, your physiology, your history, and your inputs to root cause. Not a diagnosis and a prescription. A thread that actually goes somewhere.
Start Your Map